Exploring 4C-T. To explore a different substance…

Names:
4C-T · 1-(2,5-Dimethoxyphenyl-4-methylthio)-2-aminobutane · α-Ethyl-2,5-dimethoxy-4-methylthiophenethylamine
IUPAC name:
1-[2,5-Dimethoxy-4-(methylsulfanyl)phenyl]butan-2-amine
ID: 330 · Formula: C13H21NO2S · Molecular weight: 255.376
InChI: InChI=1S/C13H21NO2S/c1-5-10(14)6-9-7-12(16-3)13(17-4)8-11(9)15-2/h7-8,10H,5-6,14H2,1-4H3/t10-/m0/s1

Standridge, RT; Howell, HG; Tilson, HA; Chamberlain, JH; Holava, HM; Gylys, JA; Partyka, RA; Shulgin, AT. Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes. J. Med. Chem., 1 Jan 1980, 23 (2), 154–162. 1125 kB. http://dx.doi.org/10.1021/jm00176a010

Gallardo-Godoy, A; Fierro, A; McLean, TH; Castillo, M; Cassels, BK; Reyes-Parada, M; Nichols, DE. Sulfur-substituted α-alkyl phenethylamines as selective and reversible MAOA inhibitors: Biological activities, CoMFA analysis, and active site modeling. J. Med. Chem., 1 Jan 2005, 48 (7), 2407–2419. 901 kB. http://dx.doi.org/10.1021/jm0493109

Partyka, RA; Standridge, RT; Howell, HG; Shulgin, AT. 2-Amino-1-(2,5-dimethoxyphenyl)butanes. U.S. Patent 4,105,695, 8 Aug 1978. 645 kB.

N-Me-4C-T
ALEPH
2C-T
ARIADNE
4C-H
4C-DOB
4C-I
4C-E
4C-IP
4C-P
4C-BU
4C-HO
4C-EtO
4C-PrO
4C-iPrO
4C-NO
4C-NH
4C-Cl
4C-HM
4C-HE
4C-MeO
4C-T-2
4C-T-7
ALEPH-2
2C-T-4
ψ-2C-T-4
2C-T-7
3-TASB
4-TASB
5-TASB
TP
3-TSB
4-TSB
2CT2-2ETO
2CT2-5ETO
2,4,3-2C-T-7
3,4,2-2C-T-7
2,3,4-2C-T-7
3,5,2-2C-T-7
2,3,5-2C-T-7
4,5,2-2C-T-7
N-Me-ALEPH
3,4,5-2C-T-7
2,6,3-2C-T-7
3,6,2-2C-T-7
2,3,6-2C-T-7
4,6,2-2C-T-7
ψ-ALEPH-2
ψ-2C-T-7
DOMSM
N-Me-4C-T
ALEPH
2C-T
ARIADNE
4C-H
4C-DOB
4C-I
4C-E
4C-IP
4C-P
4C-BU
4C-HO
4C-EtO
4C-PrO
4C-iPrO
4C-NO
4C-NH
4C-Cl
4C-HM
4C-HE
4C-MeO
4C-T-2
4C-T-7
ALEPH-2
2C-T-4
ψ-2C-T-4
2C-T-7
3-TASB
4-TASB
5-TASB
TP
3-TSB
4-TSB
2CT2-2ETO
2CT2-5ETO
2,4,3-2C-T-7
3,4,2-2C-T-7
2,3,4-2C-T-7
3,5,2-2C-T-7
2,3,5-2C-T-7
4,5,2-2C-T-7
N-Me-ALEPH
3,4,5-2C-T-7
2,6,3-2C-T-7
3,6,2-2C-T-7
2,3,6-2C-T-7
4,6,2-2C-T-7
ψ-ALEPH-2
ψ-2C-T-7
DOMSM
2 December 2016 · Creative Commons BY-NC-SA ·